Bioventus Inc (BVS) — Cash Flow Reinvestment Rate
Latest as of March 2026:
0.06x
Bioventus Inc (BVS) has a Cash Flow Reinvestment Rate of 0.06x as of March 2026, reinvesting $574.00K (capex $574.00K ) from operating cash flow of $8.93 Million. Explore Bioventus Inc (BVS) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.06x
(Capex + Investments) / Operating CF
Total Reinvested
$574.00K
Capex + Investments
Operating Cash Flow
$8.93 Million
USD
Capital Expenditures
$574.00K
USD
Bioventus Inc Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Bioventus Inc across 10 annual periods. Also explore total assets of Bioventus Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Bioventus Inc (2013–2025)
Year-by-year capital reinvestment analysis for Bioventus Inc. For live market cap and broader valuation context, see Bioventus Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | $2.56 Million | $73.98 Million | $2.56 Million | ▼ -94.4% |
| 2024 | 0.62x | $23.97 Million | $38.80 Million | $1.01 Million | ▼ -53.4% |
| 2023 | 1.33x | $20.36 Million | $15.34 Million | $7.36 Million | ▲ +46.0% |
| 2021 | 0.91x | $20.89 Million | $22.99 Million | $7.37 Million | ▲ +58.5% |
| 2020 | 0.57x | $41.17 Million | $71.80 Million | $20.67 Million | ▲ +43.6% |
| 2019 | 0.40x | $16.25 Million | $40.71 Million | $8.34 Million | ▲ +48.3% |
| 2018 | 0.27x | $12.16 Million | $45.19 Million | $6.06 Million | ▼ -31.6% |
| 2015 | 0.39x | $7.44 Million | $18.92 Million | $7.44 Million | ▼ -71.5% |
| 2014 | 1.38x | $20.83 Million | $15.11 Million | $20.83 Million | ▼ -40.4% |
| 2013 | 2.31x | $6.36 Million | $2.75 Million | $6.36 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow